Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study. - Vanni KMM; McCarter KR; Wang X; Duffy C; Cruz JPD; Wobma H; Nikiforow S; Massarotti EM; Costenbader KH; Little JS; Gravallese EM; McDermott GC; et al. (The Lancet. Rheumatology, 2025)